ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 2 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $184 | -15.6% | 8,884 | -23.6% | 0.00% | 0.0% |
| Q1 2023 | $218 | -99.8% | 11,628 | +158.5% | 0.00% | – |
| Q2 2021 | $110,000 | -44.7% | 4,499 | -41.7% | 0.00% | -100.0% |
| Q1 2021 | $199,000 | +22.8% | 7,711 | +154.7% | 0.00% | 0.0% |
| Q4 2020 | $162,000 | +362.9% | 3,028 | +257.1% | 0.00% | – |
| Q3 2020 | $35,000 | -27.1% | 848 | -13.9% | 0.00% | – |
| Q2 2020 | $48,000 | – | 985 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |